BSE Live
Jan 01, 16:01Prev. Close
59.25
Open Price
56.29
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
56.29 (25396)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Profit & Loss account of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | |
| 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||
| Revenue From Operations [Gross] | 8.92 | 7.59 | 4.07 | |
| Less: Excise/Sevice Tax/Other Levies | 0.28 | 0.25 | 0.25 | |
| Revenue From Operations [Net] | 8.63 | 7.34 | 3.82 | |
| Total Operating Revenues | 8.63 | 7.34 | 3.82 | |
| Other Income | 0.12 | 0.06 | 0.10 | |
| Total Revenue | 8.76 | 7.40 | 3.92 | |
| EXPENSES | ||||
| Cost Of Materials Consumed | 5.95 | 5.17 | 2.21 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.00 | 0.20 | -0.06 | |
| Employee Benefit Expenses | 0.91 | 0.70 | 0.50 | |
| Finance Costs | 0.43 | 0.07 | 0.21 | |
| Depreciation And Amortisation Expenses | 0.37 | 0.42 | 0.43 | |
| Other Expenses | 0.83 | 0.79 | 0.70 | |
| Total Expenses | 8.47 | 7.35 | 3.99 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 0.29 | 0.04 | -0.07 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 0.29 | 0.04 | -0.07 | |
| Tax Expenses-Continued Operations | ||||
| Current Tax | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.00 | 0.00 | 0.00 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.00 | 0.01 | 0.00 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 0.29 | 0.04 | -0.07 | |
| Profit/Loss From Continuing Operations | 0.29 | 0.04 | -0.07 | |
| Profit/Loss For The Period | 0.29 | 0.04 | -0.07 | |
| OTHER ADDITIONAL INFORMATION | ||||
| EARNINGS PER SHARE | ||||
| Basic EPS (Rs.) | 0.32 | 0.04 | -0.08 | |
| Diluted EPS (Rs.) | 0.32 | 0.04 | -0.08 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 |
24.11.2025
Shukra Pharma Standalone September 2025 Net Sales at Rs 5.88 crore, up 5.8% Y-o-Y
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y